Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.

Journal:

Journal of Clinical Oncology

Published:

2025-08-19

DOI:

10.1200/jco-25-00210

Affiliations:

24

Authors:

31

Go to article

Institutions	Authors	Share
IRCCS Rizzoli Orthopedic Institute (IOR), Italy	11.500000 11.500000	0.37
A.O.U. Citta della Salute e della Scienza di Torino, Italy	2.000000	0.06
IRCCS National Cancer Institute (INT) Milan, Italy	2.000000	0.06
Vall d'Hebron University Hospital (HUVH), ICS, Spain	1.000000	0.03
IRCCS Istituto Giannina Gaslini, Italy	1.000000	0.03
Virgen del Rocío University Hospital, Spain	1.000000	0.03
Gregorio Marañon University Hospital, Spain	1.000000	0.03
Ospedale Santa Chiara di Trento, Italy	1.000000	0.03
IRCCS Bambino Gesù Children's Hospital, Italy	1.000000	0.03
Hospital Universitario Ramón y Cajal, Spain	1.000000	0.03
SJD Barcelona Children's Hospital​ for Maternal and Child Health, BMA, Spain	1.000000	0.03
Hospital Universitario Virgen de la Arrixaca, Spain	1.000000	0.03
Hospital Infantil Universitario Niño Jesús, Spain	1.000000	0.03
University of Padova (UNIPD), Italy	1.000000	0.03
IRCCS Regina Elena National Cancer Institute (IRE), Italy	1.000000	0.03
Hospital de la Santa Creu i Sant Pau, Spain	1.000000	0.03
Sylvester Comprehensive Cancer Center (Sylvester), UM, United States of America (USA)	0.833333	0.03
IRCCS Meyer Children's Hospital, Italy	0.500000	0.02
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Italy	0.500000	0.02
Hospital Universitario Fundación Jiménez Díaz (FJD), UAM, Spain	0.333333	0.01
Hospital Universitario General de Villalba, Spain	0.333333	0.01

Interested in Oncology and Carcinogenesis?